<DOC>
	<DOCNO>NCT00932607</DOCNO>
	<brief_summary>Objective study show , exploratory basis , treatment SUBLIVAC Birch also effective compare treatment Staloral Birch mean reduction allergic symptom nasal provocation subject suffer IgE mediate allergic complaint trigger birch pollen .</brief_summary>
	<brief_title>SUBLIVAC® Birch PROBE Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Subjects allergic rhinoconjunctivitis without mild asthma ( FEV1 ≥ 70 % ) due birch pollen least 2 year . Use antiallergy symptomatic medication last birch pollen season ( case season low pollen count , one two previous year ) . No seasonal allergic complaint induce birch , grass mugwort pollen least 4 week absence rescue medication least last 2 week baseline . A positive SPT ( diameter ≥3 mm ) birch pollen positive specific serum anti birch IgEtest ( &gt; 1 U/ml ) . A positive TNPT birch allergen extract contain concentration 10 , 100 1000 AU/ml baseline visit . Age 18 year old . Subjects shall give write informed consent . A positive SPT ( diameter ≥ 3mm ) hazel alder maintenance dose reach 8 October 2009 . A positive SPT ( diameter ≥ 3mm ) pet symptoms relate concomitant sensitization pet animals home . A positive SPT ( diameter ≥ 3mm ) house dust mite mould clinically relevant symptom relate concomitant sensitization house dust mite mould , base investigator 's research ( TNPT example ) . Allergy excipients SUBLIVAC Birch Staloral Birch . Chronic asthma emphysema , particularly FEV1 &lt; 70 % predict value use inhalation corticosteroid outside grass tree pollen season two episode and/or longer fourteen day . Specific finding nose mouth screen rhinoscopy TNPT . Serious immunopathological disease malignancy ( include autoimmune disease , tuberculosis , HIV ) . Inflammation infection target organ ( nose , eyes lung ) . Severe atopic dermatitis require systemic immunosuppressive medication . Allergen specific immunotherapy treatment period longer 3 month within last 5 year . History life threaten anaphylactic event , include anaphylactic food allergy , insect venom anaphylaxis , exercise drug induce anaphylaxis . A positive pregnancy test , lactation inadequate contraceptive measure . ( adequate measure : oral contraceptive , IUD , condom use sexual relationship man ) Alcohol drug abuse . Lack cooperation severe psychological disorder . Completed ongoing longterm treatment tranquilizer psycho active drug . Low compliance inability understand instructions/study document Completed ongoing treatment antiIgEantibody Patients relationship dependence sponsor investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>seasonal</keyword>
	<keyword>rhinitis</keyword>
	<keyword>rhinoconjunctivitis</keyword>
	<keyword>birch pollen</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>sublingual</keyword>
</DOC>